lobbying_activities: 471681

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
471681	bc25f627-ef32-446e-9a56-9f9fbc9e2e32	YY	MR. MARK SHARPE	83455	ANAZAOHEALTH CORPORATION	2006	year_end	PHA	The Controlled Substance Act - and clarification of rule interpretations regarding the proper dispensing of controlled substances to patients and their physicians. There is no related bill. This was a request for clarification regarding the rules pertaining to the Act.	SENATE			0	0	2007-02-08T12:08:38-05:00